BrainZell

BrainZell are developing synthetic 3D models replicating the human brain so that pharmaceutical companies can test their drugs quicker and cheaper. Their technology also enables more ethical drug development as it reduces the testing of drugs on live animals.

Summary

Stage:

Pre-Seed

Sector:

BioTech

Investment year:

2024